FFA
CERE

Farther Finance Advisors’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Farther Finance Advisors’s Portfolio CERE Stock Details CERE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-43
Closed -$1.78K – 4177
2024
Q2 		$1.78K Buy
43
+40
+1,333% +$1.65K ﹤0.01% 2839
2024
Q1 		$127 Hold
3
– – ﹤0.01% 3342
2023
Q4 		$127 Buy
+3
New +$127 ﹤0.01% 3283